
Novomix 30 Penfill 100 Iu Inj 3 Ml Cartridge (5 Pcs)
Insulin Aspart undefined (30%) + undefined Insulin Aspart Protamine (70%)
Source ID: 243029
₹4685.12
₹3699.37
(Inclusive of all taxes)Batch
-
PKG
3 ML
Expiry
-
MRP
₹4685.12
Stock
14
Discount
21.04%
Description
NOVOMIX 30 PENFILL 100 IU INJ 3 ML CARTRIDGE
NovoMix 30 Penfill is a modern insulin (insulin analogue) product designed for managing blood sugar levels in individuals with diabetes mellitus. It combines both rapid-acting and intermediate-acting insulin to provide comprehensive glucose control.
-
Name
- Common Name: Insulin Aspart
- Brand Name: NovoMix 30 Penfill
-
Composition NovoMix 30 contains a biphasic suspension of insulin aspart. It consists of 30% soluble insulin aspart, which is rapid-acting, and 70% protamine-crystallised insulin aspart, which provides an intermediate-acting effect.
-
Uses NovoMix 30 Penfill is prescribed for the treatment of diabetes mellitus (Type 1 and Type 2) in adults, adolescents, and children aged 10 years and above. It helps to lower high blood sugar levels after meals and throughout the day by facilitating glucose uptake into muscle and fat cells, and by reducing glucose production in the liver. It can be used as monotherapy or in combination with other oral antidiabetic medications.
-
Dosage and Administration This medicine is administered via subcutaneous injection (under the skin) in areas such as the abdominal wall, thigh, deltoid, or gluteal region. It should not be administered intravenously or intramuscularly, and is not suitable for insulin infusion pumps. The injection site should be rotated within the same region to prevent skin changes. NovoMix 30 is generally given immediately before a meal (within 10 minutes) or, if necessary, soon after the start of a meal. Dosage is individualized based on patient needs and requires regular blood glucose monitoring.
-
Side Effects
- Common: The most frequently reported side effect is hypoglycemia (low blood sugar), which can manifest as cold sweat, headache, rapid heartbeat, hunger, confusion, and shakiness. Other common effects include injection site reactions such as pain, redness, itching, bruising, or swelling, as well as lipodystrophy (skin thickening or shrinking) at the injection site. Temporary vision problems and weight gain may also occur.
- Serious: Rare but potentially life-threatening systemic allergic reactions can occur.
-
Precautions Close monitoring for signs of hypoglycemia is essential, and patients should always carry sugary food. Alcohol consumption may alter blood sugar levels. Do not use NovoMix 30 if the resuspended liquid is not uniformly white and cloudy, or if the cartridge has been frozen, dropped, or damaged. Needles and cartridges must not be shared. Patients should exercise caution when driving or operating machinery due to potential blood sugar fluctuations. Inform your doctor about all medicines, vitamins, and supplements being taken, as some may interact with NovoMix 30. Dose adjustments may be necessary during illness, changes in diet or physical activity, and during pregnancy or breastfeeding.
-
Storage Unopened NovoMix 30 Penfill cartridges should be stored in a refrigerator at 2°C to 8°C, away from the cooling element and freezer. Once in use or carried as a spare, the cartridge should be kept at room temperature (below 30°C) for a maximum of 4 weeks and should not be refrigerated. Protect from excessive heat, light, and do not freeze. Keep the cartridges in their outer carton to protect from light when not in use. Discard any in-use Penfill after 4 weeks, even if some medicine remains.
₹4685.12
₹3699.37
(Inclusive of all taxes)Shop by Frequently Purchased Items
Frequently Asked Questions
NovoMix 30 Penfill 100 IU Inj 3 ml Cartridge: Frequently Asked Questions
NovoMix 30 Penfill is an insulin product used to manage blood sugar levels in individuals with diabetes. Below are some frequently asked questions about this medication.
What is NovoMix 30 Penfill used for?
NovoMix 30 Penfill is used to reduce high blood sugar levels in adults, adolescents, and children aged 10 years and above who have diabetes mellitus (both type 1 and type 2). It can be used as a standalone treatment or in combination with other oral anti-diabetic medications or injectable products.
How does NovoMix 30 Penfill work?
NovoMix 30 is a modern insulin (insulin analogue) that combines a rapid-acting component (30% soluble insulin aspart) and an intermediate-acting component (70% protamine-crystallised insulin aspart). It works by helping muscle and fat cells absorb glucose from the blood and by reducing the liver's production of glucose, thereby lowering blood sugar. The medication starts to lower blood sugar within 10–20 minutes of injection, reaches its maximum effect between 1 and 4 hours, and can last for up to 24 hours.
What is the usual dosage for NovoMix 30 Penfill?
The dosage of NovoMix 30 Penfill is individualized and determined by your doctor based on your specific needs. For individuals with type 2 diabetes, a typical starting dose might be 6 units at breakfast and 6 units at dinner, or 12 units once daily at dinner. If the once-daily dose reaches 30 units, it is generally recommended to split it into equal breakfast and dinner doses. For type 1 diabetes, the usual daily insulin requirement is between 0.5 and 1.0 unit/kg/day, which NovoMix 30 can help fulfill. It is generally taken immediately before a meal (within 10 minutes), or sometimes soon after a meal if necessary.
What are the possible side effects of NovoMix 30 Penfill?
The most common side effect is low blood sugar (hypoglycemia), which can affect more than 1 in 10 people. Symptoms of low blood sugar include cold sweat, cool pale skin, headache, rapid heartbeat, feeling sick or very hungry, temporary changes in vision, drowsiness, unusual tiredness, weakness, nervousness, tremor, anxiety, confusion, and difficulty concentrating. Severe hypoglycemia can lead to unconsciousness.
Other possible side effects include allergic reactions (such as rash, itching, or hives), and changes at the injection site like lipoatrophy (shrinking of fatty tissue) or lipohypertrophy (thickening of fatty tissue). Less commonly, some people may experience visual problems or swollen hands and feet when first starting insulin treatment. Serious allergic reactions, though very rare, can be life-threatening and require immediate medical attention if signs like difficulty breathing, rapid heartbeat, or dizziness occur.
Is NovoMix 30 Penfill safe during pregnancy or breastfeeding?
Pregnancy: There is limited clinical experience with insulin aspart during pregnancy. If you are pregnant, think you may be pregnant, or are planning a baby, consult your doctor. Your insulin dose may need to be adjusted during pregnancy and after delivery, and careful control of your diabetes is crucial for the health of your baby.
Breastfeeding: There are no restrictions on using NovoMix 30 while breastfeeding. Insulin treatment for the nursing mother poses no known risk to the baby, though your NovoMix 30 dose may need to be adjusted.
Can NovoMix 30 Penfill be taken with other medications?
Many medications can influence your blood sugar levels and may necessitate an adjustment in your insulin dose. Some medicines that may reduce insulin requirements include other oral antidiabetic drugs, MAOIs (monoamine oxidase inhibitors), beta-blockers, ACE (angiotensin-converting enzyme) inhibitors, salicylates, anabolic steroids, sulfonamides, and alcohol. Conversely, some medicines that may increase insulin requirements include oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, and danazol. Beta-blockers can also mask the warning symptoms of low blood sugar.
It is important to inform your doctor if you are taking pioglitazone, as the combination with insulin has been linked to heart failure in some patients with long-standing type 2 diabetes and heart conditions or a history of stroke. NovoMix 30 should not be mixed with other medicinal products.
What precautions should be taken when using NovoMix 30 Penfill?
Do not use NovoMix 30 Penfill if you are allergic to insulin aspart or any other ingredients, or if you suspect you are experiencing low blood sugar. This medication should not be used in insulin infusion pumps. Before each use, inspect the cartridge for any damage; do not use it if it has been dropped, damaged, frozen, or if the insulin suspension does not appear uniformly white, cloudy, and aqueous after resuspension. Always rotate your injection sites to help prevent skin changes like thickening or shrinking of fatty tissue. Use a new needle for each injection and never share needles or cartridges. Always carry a source of sugary food or drink to treat low blood sugar. Be cautious with alcohol consumption as it can significantly affect your blood sugar levels. Your doctor may need to adjust your dose and monitoring frequency during illness, when traveling across time zones, if you have kidney or liver problems, or if you are over 65 years old. Be aware that low blood sugar can impair your concentration and reaction time, which may affect your ability to drive or operate machinery.
What happens if a dose is missed?
If you miss a dose of NovoMix 30 Penfill, your blood sugar levels may become too high (hyperglycemia). If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you remember shortly after missing a dose, take it as soon as possible and consume carbohydrates within 10 minutes, then resume your normal schedule. It is always best to consult your doctor or pharmacist if you are unsure.
How should NovoMix 30 Penfill be stored?
Unopened cartridges: Store NovoMix 30 Penfill cartridges in a refrigerator between 2°C and 8°C. They must not be frozen and should be kept away from the cooling element. Always store them in their outer carton to protect them from light.
Cartridges in use or carried as a spare: Do not store these in the refrigerator. They can be kept at room temperature (below 30°C) for up to 4 weeks. After 4 weeks, the cartridge should be discarded, even if there is still some medicine left. Protect the cartridge from excessive heat and direct light. Before each use, ensure the insulin is resuspended correctly and appears uniformly white, cloudy, and aqueous.












































